- Home
- UL vs SYK Comparison
UL vs SYK Comparison
Compare UL & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UL
- SYK
- Stock Information
- Founded
- UL 1930
- SYK 1941
- Country
- UL United Kingdom
- SYK United States
- Employees
- UL N/A
- SYK N/A
- Industry
- UL Package Goods/Cosmetics
- SYK Medical/Dental Instruments
- Sector
- UL Consumer Discretionary
- SYK Health Care
- Exchange
- UL Nasdaq
- SYK Nasdaq
- Market Cap
- UL 143.0B
- SYK 146.1B
- IPO Year
- UL N/A
- SYK N/A
- Fundamental
- Price
- UL $57.91
- SYK $389.35
- Analyst Decision
- UL Buy
- SYK Buy
- Analyst Count
- UL 4
- SYK 19
- Target Price
- UL $60.00
- SYK $395.42
- AVG Volume (30 Days)
- UL 2.1M
- SYK 1.4M
- Earning Date
- UL 07-25-2024
- SYK 10-29-2024
- Dividend Yield
- UL 3.28%
- SYK 0.82%
- EPS Growth
- UL N/A
- SYK 38.37
- EPS
- UL 2.82
- SYK 9.33
- Revenue
- UL $64,601,950,064.00
- SYK $21,974,000,000.00
- Revenue This Year
- UL $2.95
- SYK $11.34
- Revenue Next Year
- UL $3.20
- SYK $8.11
- P/E Ratio
- UL $19.97
- SYK $41.74
- Revenue Growth
- UL N/A
- SYK 10.51
- 52 Week Low
- UL $46.46
- SYK $285.79
- 52 Week High
- UL $65.87
- SYK $398.15
- Technical
- Relative Strength Index (RSI)
- UL 32.02
- SYK 68.49
- Support Level
- UL $56.87
- SYK $380.21
- Resistance Level
- UL $57.65
- SYK $392.70
- Average True Range (ATR)
- UL 0.52
- SYK 8.51
- MACD
- UL -0.25
- SYK 2.23
- Stochastic Oscillator
- UL 20.68
- SYK 79.34
About UL Unilever PLC
Unilever is a diversified personal-care (52% of 2022 sales by value), homecare (14%), and packaged food (34%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Axe and Dove skin products, and the TRESemmé haircare brand. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, Garancia, and The Vegetarian Butcher.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.